Obsidian Therapeutics, Inc.

Obsidian Therapeutics, Inc. financial statements

Obsidian Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 100.61MEODHD
Cash and equivalentsUSD 40.41MEODHD
Total debtUSD 4.28MEODHD

Obsidian Therapeutics, Inc. financials on 6ix · Obsidian Therapeutics, Inc. on 6ix